ANDA 78878, held by Dr Reddys Labs Ltd. Omeprazole Magnesium.
As of Nov 16, 2026, ANDA 78878 (Omeprazole Magnesium), held by Dr Reddys Labs Ltd, was first approved by FDA on Jun 5, 2009, with 10 approved supplements and 0 published complete response letters.
Uses treats frequent heartburn (occurs 2 or more days a week) not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 2009 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Omeprazole MagnesiumEQ 20MG BASE · capsule, delayed release;oral | Omeprazole Magnesium | OTC |
| Jun 2, 2023 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jun 2, 2023 | Supplement 30Labeling · Standard review | Approved | None posted |
| Jun 2, 2023 | Supplement 32Labeling · Standard review | Approved | None posted |
| Jun 2, 2023 | Supplement 42Labeling · Standard review | Approved | None posted |
| Jun 8, 2016 | Supplement 22Labeling · Standard review | Approved | None posted |
| Apr 6, 2015 | Supplement 10Labeling | Approved | None posted |
| Feb 14, 2014 | Supplement 15Manufacturing | Approved | None posted |
| Oct 31, 2013 | Supplement 12Labeling · Standard review | Approved | None posted |
| Aug 27, 2012 | Supplement 11Labeling | Approved | None posted |
| Nov 23, 2010 | Supplement 6Labeling | Approved | None posted |
| Jun 5, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters